ClinicalTrials.gg
RecruitingNCT05706831Updated Nov 10, 2026

Music Intervention and Transcranial Electrical Stimulation for Neurological Diseases

An interventional study of Combinatory effect of music stimulation and neurostimulation in Disorder of Consciousness and Stroke, sponsored by Istituti Clinici Scientifici Maugeri SpA. Recruiting at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Istituti Clinici Scientifici Maugeri SpA · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Sep 2022; still recruiting 4 years 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 28 studies in Consciousness Disorders with a site in Italy — 10 open to participants now, 10 under way, 1 of them phase 3. Consciousness Disorders · Italy.

Planned enrollment
5th of 12
90 · median 40
Started
2022
with 1 other
No phase
10 of 28
3 open now
Registered
7th of 28
by date

Among the 28 studies in Consciousness Disorders with a site in Italy, this one is the 5th largest by planned enrollment of the 12 interventional ones that give a count, is one of 2 that started in 2022, is one of 10 with no phase, and was the 7th registered.

Consciousness Disorders

291 studies on the registry are indexed under Consciousness Disorders; 109 are open to participants now.

Browse Consciousness Disorders studies →

Open to participants now

10 of the 28 studies in Consciousness Disorders with a site in Italy are open now. Recruiting first, the newest first:

4 more — sign in →

All 10 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 74 Consciousness Disorders studies recruiting now, 31 (42%) set no upper age limit and 24 (32%) stop at 75 or younger; 12 take children under 18; 15 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 28 studies in Consciousness Disorders with a site in Italy, or all of them as a file.
02

Study summary

The goal of this clinical trial is to evaluate the efficacy of a musical interventionand non-invasive brain stimulation in neurological patients. The main questions it aims to answer are:

  • to evaluate the residual neuroplastic processes in DOC state related to music exposure
  • to determine the putative modulation of the aforementioned processes and the clinical outcome of DOC patients by non-pharmacological strategies, i.e., electric (tDCS) and music stimulation
  • to evaluate the impact of this intervention on caregiver's burden and psychological distress.

Participants will be randomly assigned to one of three different music-listening intervention groups. Primary outcomes will be clinical, that is based on the neurologist's observations of clinical improvement, and neurophysiological, collected pre-intervention, post-intervention and post-placebo.

03

Conditions studied

  • Disorder of Consciousness
  • Stroke

Keywords

  • music stimulation
  • tDCS
  • Aphasia
  • Neglect
  • DOC
  • Stroke
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age > 18 years
  • Post-stroke aphasia
  • Post-stroke neglect
  • Patients with disorders of consciusness (DOC)

Exclusion criteria

Exclusion Criteria:

  • No auditory injury
  • no hystory of neurological disease
  • No hystory of psychiatric disease
  • Previous stroke
  • use of alcohol and drugs
  • premorbid dementia
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Group 1

    Group 1 will receive tEs combined with music stimulation for 2 weeks, 1 week of wash out, then sham stimulation combined with noise (placebo) for other 2 weeks.

    Other: Combinatory effect of music stimulation and neurostimulation

  • Experimental
    Group 2

    Group 2 will receive sham stimulation and noise (placebo) for the first 2 weeks, then 1 week wash out, and finally tEs and music stimulation for other 2 weeks.

    Other: Combinatory effect of music stimulation and neurostimulation

  • Experimental
    Group 3

    Group 3 will receive only music stimulation and sham stimulation for 2 weeks, 1 week of wash out, then sham stimulation and noise (placebo) for another 2 weeks.

    Other: Combinatory effect of music stimulation and neurostimulation

Interventions

  • OtherCombinatory effect of music stimulation and neurostimulation

    music

06

What researchers measure

Primary outcomes

  1. Neuropsychological outcomes

    -Coma Recovery Scale-Revised (CRS-R) - (0-23). High score means a better outcome.

    Time frame: Change from baseline Coma Recovery Scale- Revised at 2 weeks and 4 weeks

  2. Neuropsychological outcomes

    Disability Rating Scale (DRS) - (0-29). High score means a worse outcome.

    Time frame: Change from baseline Disability Rating Scale at 2 weeks and 4 weeks

  3. Neuropsychological outcomes

    Rancho Levels of Cognitive Functioning (LCF) - (1-8). High score means a better outcome.

    Time frame: Change from baseline Rancho Levels of Cognitive Functioning at 2 weeks and 4 weeks

  4. Neuropsychological outcomes

    Glasgow Outcome Scale- Extended (GOS-E) - (1-8). High score means a better outcome.

    Time frame: Change from baseline Glasgow Outcome Scale- Extended at 2 weeks and 4 weeks

  5. Neuropsychological outcomes

    Aachener Aphasie Test (AAT). This test includes six subtests: spontaneous speech, token test, repetition, written language, naming, and comprehension. Spontaneous speech is structured in six parts (0-30). High score means a better performance; Token test is composed by 50 items; for the score the number of error id considered (0-50). Repetition sub test is composed by 50 items; for each item the score range from 0 to 3; high score means better outcome (0-150). Written language subtest is composed by 30 items; for each item the score range from 0 to 3; high score means better outcome (0-90). Naming subtest is composed by 40 items; for each item the score range from 0 to 3; high score means better outcome (0-120). Comprehension subtest is composed by 40 items; for each item the score range from 0 to 3; high score means better outcome (0-120).

    Time frame: Change from baseline Aachener Aphasie Test at 2 weeks and 4 weeks

  6. Neuropsychological outcomes

    Italian version of Functional Outcome Questionnaire for Aphasie (FOQ-A) - (32-160). High score means a better outcome.

    Time frame: Change from baseline Italian version of Functional Outcome Questionnaire for Aphasie at 2 weeks and 4 weeks

  7. Neuropsychological outcomes

    Functional Assessment Measure - Cognitive subscale - (FAM) - (14-98); high score means a better outcome.

    Time frame: Change from baseline Functional Assessment Measure - Cognitive subscale at 2 weeks and 4 weeks

  8. Neuropsychological outcomes

    Quality of Life questionnaire for Aphasics (QLQA) - (0-148); High score means a better outcome.

    Time frame: Change from baseline Quality of Life Questionnaire for aphasics at 2 weeks and 4 weeks

  9. Neuropsychological outcomes

    The semi-structured scale for functional evaluation of personal neglect - (0-9); High score means a worse outcome.

    Time frame: Change from baseline The semi-structured scale for functional evaluation of personal neglect at 2 weeks and 4 weeks

  10. Neuropsychological outcomes

    Barrage test (0-36). High score means a better outcome.

    Time frame: Change from baseline Barrage Test at 2 weeks and 4 weeks

  11. Neuropsychological outcomes

    Letter cancellation test - (0-104). High score means a better outcome.

    Time frame: Change from baseline Letter cancellation test at 2 weeks and 4 weeks

  12. Neuropsychological outcomes

    Sentence reading test (0-6). High score means a worse outcome.

    Time frame: Change from baseline Sentence reading test at 2 weeks and 4 weeks

  13. Neuropsychological outcomes

    Wundt-Jastrow area illusion test (0-20). High score means a worse outcome.

    Time frame: Change from baseline Wundt-Jastrow area illusion test at 2 weeks and 4 weeks

  14. Neuropsychological outcomes

    The semi structured scale for the functional evaluation of extrapersonal neglect (0-9). High score means a worse outcome.

    Time frame: Change from baseline The semi structured scale for the functional evaluation of extrapersonal neglect at 2 weeks and 4 weeks

  15. Neurophysiological outcome

    The ratio of fast (8-30 Hz, α-β) to slow (2-8 Hz, δ-θ) oscillation amplitude at the midline electrodes (Fz, Cz, Pz, Oz) will be measured and compared pre- and post intervention."

    Time frame: Change from baseline oscillation at 2 weeks and 4 weeks

Secondary outcomes

  1. Caregiver psychological distress

    Back depression Inventory II (BDI II) - (0-63). High score means a worse outcome.

    Time frame: Change from baseline Back depression Inventory II at 2 weeks and 4 weeks

  2. Caregiver psychological distress

    State-trait anxiety inventory (STAI-Y). It is composed by two scales: STAI-Y State (20-80) and STAI-Y Trait (20-80). High score means a worse outcome.

    Time frame: Change from baseline State-trait anxiety inventory; at 2 weeks and 4 weeks

  3. Caregiver psychological distress

    Psychophysiological Questionnaire (30-120). WHOQOL-BREF.

    Time frame: Change from baseline Questionario psicofisiologico (CBA) at 2 weeks and 4 weeks

  4. Caregiver psychological distress

    Prolonged grief disorder -12 (PG-12) - (11-55). High score means a worse outcome.

    Time frame: Change from baseline Prolonged grief disorder -12 at 2 weeks and 4 weeks

  5. Caregiver psychological distress

    Family strain questionnaire (FSQ) - (1-44). High score means a worse outcome.

    Time frame: Change from baseline Family strain questionnaire at 2 weeks and 4 weeks

  6. Caregiver psychological distress

    better outcome.

    Time frame: Change from baseline Wolrd health organization - quality of life at 2 weeks and 4 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Spaccavento S, Carraturo G, Brattico E, Matarrelli B, Rivolta D, Montenegro F, Picciola E, Haumann NT, Jespersen KV, Vuust P, Losavio E. Musical and electrical stimulation as intervention in disorder of consciousness (DOC) patients: A randomised cross-over trial. PLoS One. 2024 May 31;19(5):e0304642. doi: 10.1371/journal.pone.0304642. eCollection 2024. PubMed 38820520 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2022 (actual). Primary completion is estimated for Dec 2026, 51 months after the start.

Of 90 non-industry interventional studies with no phase under Consciousness Disorders, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 64. This study's planned 51 months is above that.

Counting every sponsor, half of 95 studies reached it within 19 months; a quarter within 8 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 16, 2022
First posted
Jan 31, 2023
StartActual
Sep 1, 2022
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Publications
1 publication citing this study linked from PubMed, e.g. PubMed 38820520 ↗
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    Publications 1 publication citing this study linked from PubMed, e.g. PubMed 38820520 ↗
    + 4 other changes: verification date, responsible party, oversight details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05706831
Collaborators
University of Bari Aldo Moro, University of Aarhus
Responsible party
Sponsor
First posted
Jan 31, 2023
Start date
Sep 1, 2022
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Nov 10, 2026

Study contacts

Simona Spaccavento
Contact
simona.spaccavento@icsmaugeri.it
+393332783524

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion